BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu LN, Zou SQ, Wang JM. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3719-3723 [PMID: 15968727 DOI: 10.3748/wjg.v11.i24.3719] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Zimmermann A. Adenocarcinoma of the Gallbladder: Biology of Disease, Prognosticators, and Staging. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_148] [Reference Citation Analysis]
2 Zimmermann A. Adenocarcinoma of the Gallbladder: Biology of Disease, Prognosticators, and Staging. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_148-1] [Reference Citation Analysis]
3 Rai R, Sharma KL, Sharma S, Misra S, Kumar A, Mittal B. Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population. PLoS One 2014;9:e90264. [PMID: 24587306 DOI: 10.1371/journal.pone.0090264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hariprasad G, Hariprasad R, Kumar L, Srinivasan A, Kola S, Kaushik A. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers. Biomarkers 2013;18:532-41. [PMID: 23902290 DOI: 10.3109/1354750X.2013.822561] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
5 Roa JC, Adsay NV. Molecular Pathology of Gallbladder Cancer. Molecular Surgical Pathology 2013. [DOI: 10.1007/978-1-4614-4900-3_4] [Reference Citation Analysis]
6 Maurya SK, Tewari M, Mishra RR, Shukla HS. Genetic abberations in gallbladder cancer. Surgical Oncology 2012;21:37-43. [DOI: 10.1016/j.suronc.2010.09.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
7 Li Q, Peng J, Li XH, Liu T, Liang QC, Zhang GY. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues. World J Gastroenterol 2010; 16(10): 1274-1278 [PMID: 20222173 DOI: 10.3748/wjg.v16.i10.1274] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
8 Hu DM, Wang SF, Feng YZ. Expression of matrix metalloproteinase-7 and Fas and their significances in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2006; 14(33): 3237-3240 [DOI: 10.11569/wcjd.v14.i33.3237] [Reference Citation Analysis]